Breast cancer patients taking the drug tamoxifen can cut their chances of having the disease come back or kill them if they stay on the pills for 10 years instead of five years as doctors recommend now, a major study finds. In the new study, presented Wednesday at a breast cancer conference in San Antonio, researchers found that women who took tamoxifen for 10 years lowered their risk of a recurrence by 25 per cent and of dying of breast cancer by 29 per cent compared to those who took the pills for just five years. Read more here.
No comments:
Post a Comment